Real-world Comparative Effectiveness of Evolocumab Versus Ezetimibe in Reducing the Risk of Fatal and Nonfatal Myocardial Infarction (20240027) First published 26/03/2025 Last updated 30/04/2025 EU PAS number:EUPAS1000000522 Study Ongoing